Identifying a role for toll-like receptor 3 in the innate immune response to chlamydia muridarum infection in murine oviduct epithelial cells

Infection and Immunity

Volumn 80, Issue 1, 2012, Pages 254-265

  Derbigny, Wilbert A ^a   Shobe, Latasha R ^a   Kamran, Jasmine C ^a   Toomey, Katherine S ^a   Ofner, Susan ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCL9 CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR9; CXCL1 CHEMOKINE; CXCL11 CHEMOKINE; CXCL13 CHEMOKINE; CXCL15 CHEMOKINE; CXCL16 CHEMOKINE; CXCL9 CHEMOKINE; EOTAXIN; EOTAXIN 2; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 6; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 5; RANTES; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG; UNINDEXED DRUG; CYTOKINE; TLR3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ARTICLE; CELL DIVISION; CHLAMYDIASIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; GENITAL SYSTEM; IMMUNOPATHOGENESIS; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; MOUSE; NONHUMAN; OVIDUCT; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SECRETION; ANIMAL; C57BL MOUSE; CELL CULTURE; CHLAMYDIA; FEMALE; GENE EXPRESSION PROFILING; IMMUNOLOGY; MOUSE MUTANT;

ANIMALS; CELLS, CULTURED; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; CYTOKINES; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; IMMUNITY, INNATE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVIDUCTS; TOLL-LIKE RECEPTOR 3;

EID: 84857078093     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05549-11     Document Type: Article

References (70)

1. Aderem A. 2001. Role of Toll-like receptors in inflammatory response in macrophages. Crit. Care Med. 29:S16-S18.
2. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-_B by Toll-like receptor 3. Nature 413:732-738.
3. Al Moussawi K, et al. 2010. Type I interferon induction is detrimental during infection with the Whipple's disease bacterium, Tropheryma whipplei. PLoS Pathog. 6:e1000722.
4. Barlow RE, et al. 2001. The prevalence of Chlamydia trachomatis in fresh tissue specimens from patients with ectopic pregnancy or tubal factor infertility as determined by PCR and in-situ hybridization. J. Med. Microbiol. 50:902-908.
5. Barrenschee M, Lex D, Uhlig S. 2010. Effects of the TLR2 agonists MALP-2 and Pam3Cys in isolated mouse lungs. PLoS One 5:e13889.
6. Barton GM, Medzhitov R. 2002. Toll-like receptors and their ligands. Curr. Top. Microbiol. Immunol. 270:81-92.
7. Bekisz J, Schmeisser H, Hernandez J, Goldman ND, Zoon KC. 2004. Human interferons alpha, beta, and omega. Growth Factors 22:243-251.
8. Byrne GI, Krueger DA. 1983. Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin. Infect. Immun. 42:1152-1158.
9. Campbell LA, et al. 1993. Detection of Chlamydia trachomatis deoxyribonucleic acid in women with tubal infertility. Fertil Steril. 59:45-50.
10. Carlin JM, Borden EC, Byrne GI. 1989. Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages. J. Interferon Res. 9:329-337.
11. Cavalieri D, et al. 2010. DC-ATLAS: a systems biology resource to dissect receptor specific signal transduction in dendritic cells. Immunome Res. 6:10.
12. Darville T, et al. 2003. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J. Immunol. 171:6187- 6197.
13. Derbigny WA, Hong SC, Kerr MS, Temkit M, Johnson RM. 2007. Chlamydia muridarum infection elicits a beta interferon response in murine oviduct epithelial cells dependent on interferon regulatory factor 3 and TRIF. Infect. Immun. 75:1280-1290.
14. Derbigny WA, Johnson RM, Toomey KS, Ofner S, Jayarapu K. 2010. The Chlamydia muridarum-induced IFN-beta response is TLR3- dependent in murine oviduct epithelial cells. J. Immunol. 185:6689-6697.
15. Derbigny WA, Kerr MS, Johnson RM. 2005. Pattern recognition molecules activated by Chlamydia muridarum infection of cloned murine oviduct epithelial cell lines. J. Immunol. 175:6065- 6075.
16. Ebihara T, Shingai M, Matsumoto M, Wakita T, Seya T. 2008. Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells. Hepatology 48:48-58.
17. Fahy OL, Townley SL, McColl SR. 2006. CXCL16 regulates cell-mediated immunity to Salmonella enterica serovar Enteritidis via promotion of gamma interferon production. Infect. Immun. 74:6885- 6894.
18. Fujita H, Asahina A, Tada Y, Fujiwara H, Tamaki K. 2005. Type I interferons inhibit maturation and activation of mouse Langerhans cells. J. Invest. Dermatol. 125:126-133.
19. Gowen BB, et al. 2006. TLR3 deletion limits mortality and disease severity due to phlebovirus infection. J. Immunol. 177:6301- 6307.
20. Guillot L, et al. 2005. Involvement of Toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 280:5571-5580.
21. Huber JP, Farrar JD. 2011. Regulation of effector and memory T-cell functions by type I interferon. Immunology 132:466-474.
22. Jiang W, Pisetsky DS. 2008. The induction of HMGB1 release from RAW 264.7 cells by transfected DNA. Mol. Immunol. 45:2038-2044.
23. Johnson RM. 2004. Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion. Infect. Immun. 72:3951-3960.
24. Kopp EB, Medzhitov R. 1999. The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 11:13-18.
25. Kramp JC, McMurray DN, Formichella C, Jeevan A. 2011. The in vivo immunomodulatory effect of recombinant tumour necrosis factor-alpha in guinea pigs vaccinated with Mycobacterium bovis bacille Calmette-Guerin. Clin. Exp. Immunol. 165:110-120.
26. Lacy HM, et al. 2011. Essential role for neutrophils in pathogenesis and adaptive immunity in Chlamydia caviae ocular infections. Infect. Immun. 79:1889-1897.
27. Lee EY, Lee ZH, Song YW. 2009. CXCL10 and autoimmune diseases. Autoimmun. Rev. 8:379-383.
28. Le Goffic R, et al. 2006. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog. 2:e53.
29. Li W, Katz BP, Spinola SM. 2011. Haemophilus ducreyi lipooligosaccharides induce expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase via type I interferons and tumor necrosis factor alpha in human dendritic cells. Infect. Immun. 79:3338-3347.
30. Lien E, Zipris D. 2009. The role of Toll-like receptor pathways in the mechanism of type 1 diabetes. Curr. Mol. Med. 9:52- 68.
31. Ly LH, Jeevan A, McMurray DN. 2009. Neutralization of TNFα alters inflammation in guinea pig tuberculous pleuritis. Microbes Infect. 11: 680-688.
32. Matsumoto M, et al. 2003. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J. Immunol. 171:3154-3162.
33. Matsumoto M, Kikkawa S, Kohase M, Miyake K, Seya T. 2002. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 293:1364-1369.
34. Matsumoto M, Seya T. 2008. TLR3: interferon induction by doublestranded RNA including poly(I:C). Adv. Drug Deliv. Rev. 60:805- 812.
35. McCormack WM, et al. 1979. Fifteen-month follow-up study of women infected with Chlamydia trachomatis. N. Engl. J. Med. 300:123-125.
36. Medzhitov R, Janeway C, Jr. 2000. The Toll receptor family and microbial recognition. Trends Microbiol. 8:452- 456.
37. Mielke ME, Peters C, Hahn H. 1997. Cytokines in the induction and expression of T-cell-mediated granuloma formation and protection in the murine model of listeriosis. Immunol. Rev. 158:79-93.
38. Miller WC, et al. 2004. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 291:2229-2236.
39. Mogensen KE, Lewerenz M, Reboul J, Lutfalla G, Uze G. 1999. The type I interferon receptor: structure, function, and evolution of a family business. J. Interferon Cytokine Res. 19:1069-1098.
40. Moller BR, et al. 1979. Chlamydia trachomatis infection of the Fallopian tubes: histological findings in two patients. Br. J. Vener. Dis. 55:422- 428.
41. Muller U, et al. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921.
42. Nagarajan UM, et al. 2008. Type I interferon signaling exacerbates Chlamydia muridarum genital infection in a murine model. Infect. Immun. 76:4642- 4648.
43. Ottenhoff TH, Verreck FA, Hoeve MA, van de Vosse E. 2005. Control of human host immunity to mycobacteria. Tuberculosis (Edinb.) 85: 53-64.
44. Paavonen J. 1998. Pelvic inflammatory disease. From diagnosis to prevention. Dermatol. Clin. 16:747-756, xii.
45. Paguirigan AM, Byrne GI, Becht S, Carlin JM. 1994. Cytokine-mediated indoleamine 2,3-dioxygenase induction in response to Chlamydia infection in human macrophage cultures. Infect. Immun. 62:1131-1136.
46. Pasquinelli AE. 2002. MicroRNAs: deviants no longer. Trends Genet. 18:171-173.
47. Patton DL, et al. 1994. Detection of Chlamydia trachomatis in Fallopian tube tissue in women with postinfectious tubal infertility. Am. J. Obstet. Gynecol. 171:95-101.
48. Pyles RB, Jezek GE, Eaves-Pyles TD. 2010. Toll-like receptor 3 agonist protection against experimental Francisella tularensis respiratory tract infection. Infect. Immun. 78:1700-1710.
49. Qiu H, et al. 2008. Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection by enhancing apoptosis of local macrophages. J. Immunol. 181:2092-2102.
50. Rahm VA, Gnarpe H, Odlind V. 1988. Chlamydia trachomatis among sexually active teenage girls: lack of correlation between chlamydial infection, history of the patient and clinical signs of infection. Br. J. Obstet. Gynaecol. 95:916-919.
51. Rank RG, Whittimore J, Bowlin AK, Dessus-Babus S, Wyrick PB. 2008. Chlamydiae and polymorphonuclear leukocytes: unlikely allies in the spread of chlamydial infection. FEMS Immunol. Med. Microbiol. 54: 104-113.
52. Reiter Z. 1993. Interferon: a major regulator of natural killer cellmediated cytotoxicity. J. Interferon Res. 13:247-257.
53. Rossi DL, et al. 1999. Lungkine, a novel CXC chemokine, specifically expressed by lung bronchoepithelial cells. J. Immunol. 162:5490-5497.
54. Rudd BD, Burstein E, Duckett CS, Li X, Lukacs NW. 2005. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J. Virol. 79:3350-3357.
55. Rudd BD, et al. 2006. Deletion of TLR3 alters the pulmonary immune environment and mucus production during respiratory syncytial virus infection. J. Immunol. 176:1937-1942.
56. Schachter J (ed). 1980. Chlamydiae (psittacosis-lymphogranuloma venereum-trachoma group), 3rd ed. American Society for Microbiology, Washington, DC.
57. Schmitz JM, McCracken VJ, Dimmitt RA, Lorenz RG. 2007. Expression of CXCL15 (Lungkine) in murine gastrointestinal, urogenital, and endocrine organs. J. Histochem. Cytochem. 55:515-524.
58. Shepard MK, Jones RB. 1989. Recovery of Chlamydia trachomatis from endometrial and fallopian tube biopsies in women with infertility of tubal origin. Fertil. Steril. 52:232-238.
59. Siren J, Pirhonen J, Julkunen I, Matikainen S. 2005. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL- 29. J. Immunol. 174:1932-1937.
60. Stephens RS. 2003. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol. 11:44-51.
61. Suh HS, et al. 2009. TLR3 and TLR4 are innate antiviral immune receptors in human microglia: role of IRF3 in modulating antiviral and inflammatory response in the CNS. Virology 392:246-259.
62. van den Brule AJ, et al. 2002. Prevalence and persistence of asymptomatic Chlamydia trachomatis infections in urine specimens from Danish male military recruits. Int. J. STD AIDS 13(Suppl 2):19-22.
63. Wang T, et al. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10:1366-1373.
64. Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR. 2006. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 80:5059-5064.
65. Weigert A, et al. 2010. Cleavage of sphingosine kinase 2 by caspase-1 provokes its release from apoptotic cells. Blood 115:3531-3540.
66. Westrom L, Mardh PA. 1984. Current views on the concept of pelvic inflammatory disease. Aust. N Z J. Obstet. Gynaecol. 24:98-105.
67. Wong MM, Fish EN. 2003. Chemokines: attractive mediators of the immune response. Semin. Immunol. 15:5-14.
68. Wyrick PB. 2000. Intracellular survival by Chlamydia. Cell Microbiol. 2:275-282.
69. Yang X, Brunham RC. 1998. Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection. J. Immunol. 161:1439-1446.
70. Zhang SY, et al. 2008. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. Immunol. Rev. 226:29-40.